Related by context. All words. (Click for frequent words.) 72 nosocomial pneumonia 71 complicated intra abdominal 71 infections cIAI 69 oritavancin 69 cIAI 69 candidemia 68 cSSSIs 68 tigecycline 67 esophageal candidiasis 67 invasive candidiasis 67 posaconazole 67 micafungin 66 Noxafil 66 telavancin 66 NOXAFIL 66 TYGACIL 66 intra abdominal infections 66 daptomycin 66 invasive aspergillosis 66 methicillin resistant S. aureus 66 pancreatic insufficiency 65 TYZEKA 65 sorafenib tablets 65 miconazole Lauriad ® 65 CABP 65 Tygacil 65 candidiasis 65 Clostridium difficile associated 65 oropharyngeal candidiasis OPC 65 piperacillin tazobactam 65 amoxicillin clavulanate 65 Telavancin 64 right sided endocarditis 64 docetaxel Taxotere ® 64 amphotericin B 64 terlipressin 64 Diabetic Macular Edema 64 imipenem 64 IBS C 64 herpetic keratitis 64 alpha interferons 64 AGILECT R 64 invasive fungal infections 64 Cellegesic 64 Skin Structure Infections 64 oropharyngeal candidiasis 64 Complicated Skin 64 chronic HCV infection 63 nosocomial pneumonia NP 63 doripenem 63 non metastatic osteosarcoma 63 pediatric Crohn disease 63 ZYVOX 63 SPRYCEL ® 63 acquired pneumonia HAP 63 relapsed MM 63 interferon ribavirin 63 staphylococcal infections 63 REMICADE ® 63 oxypurinol 63 Vfend 63 sunitinib malate 63 COPD exacerbation 63 acute coronary syndromes ACS 63 PEGINTRON TM 63 diaper dermatitis 63 Ceftobiprole 63 hypereosinophilic syndrome 63 PREZISTA r 63 biologic DMARD 63 mupirocin 63 myelodysplastic myeloproliferative diseases 62 acyclovir Lauriad R 62 pseudobulbar affect PBA 62 thetreatment 62 voriconazole 62 elotuzumab 62 seborrheic dermatitis 62 CUBICIN 62 xanthine oxidase inhibitor 62 galiximab 62 ORENCIA ® 62 NXL# 62 Zenvia ™ 62 bacteremia 62 hemorrhagic cystitis 62 intravenous iclaprim 62 Cloretazine 62 hepatitis C genotype 62 Fludara 62 Infusion Reactions Severe 62 forodesine 62 TEMODAL 62 S. aureus bacteremia 62 LymphoStat B belimumab 62 oral antifungal 62 RAPTIVA 62 Irinotecan 62 ketolide antibiotic 62 Mycamine 62 CHOP chemotherapy 62 pegylated interferons 62 treat chronic sinusitis 62 venous thromboembolic events 62 dasatinib Sprycel ® 62 ceftaroline 62 anidulafungin 62 TMP SMX 62 Kamada AAT 62 Acute Bacterial Sinusitis ABS 62 TORISEL 62 invasive fungal infection 62 aztreonam 62 MYLOTARG 61 ganetespib 61 sorafenib Nexavar ® 61 potentially hepatotoxic 61 immunocompetent patients 61 refractory gout 61 Icatibant 61 Dalbavancin 61 Navelbine ® 61 prokinetic agent 61 hoFH 61 ACTEMRA TM 61 DIFICID 61 OMNARIS HFA 61 systemic fungal infections 61 indolent NHL 61 alfa 2a 61 Altastaph 61 Pemetrexed 61 AMEVIVE 61 Peginterferon alfa 2b 61 ARCOXIA 61 Candida infections 61 fidaxomicin 61 Community Acquired Pneumonia 61 mRCC 61 Sebivo 61 Fibrillex TM 61 oral vancomycin 61 refractory chronic lymphocytic 61 Actemra tocilizumab 61 MYCAMINE 61 HBeAg negative 61 vidofludimus 61 chemotherapy induced neutropenia 61 ribavirin therapy 61 DORIBAX 61 Tekamlo 61 lenalidomide Revlimid R 61 chlorambucil 61 CYT# potent vascular disrupting 61 diarrhea predominant irritable 61 Dacogen injection 61 cUTI 61 Proquin XR 61 malignant neoplasms 61 BRIM2 61 immunocompromised patients 61 CIMZIA TM 61 Mucositis 61 CANCIDAS 61 haematologic 61 Zavesca ® 61 trimethoprim sulfamethoxazole 61 lucinactant 61 Ranolazine 61 budesonide foam 61 dacarbazine 61 benign prostatic hypertrophy BPH 61 lumiliximab 61 metastatic neuroendocrine tumors 61 relapsed multiple myeloma 61 unresectable HCC 61 pouchitis 61 Toxicities 61 biologic therapy 61 superficial basal cell carcinoma 61 pseudomembranous colitis 61 Velcade bortezomib 61 reslizumab 61 lomitapide 61 peripheral sensory neuropathy 61 bendamustine 61 thromboembolic events 61 FluCAM arm 61 CDAD 61 hemorrhagic complications 61 AA Amyloidosis 61 venous stasis ulcers 61 vinorelbine 61 Kepivance 61 lupus nephritis 61 ALT flares 61 faropenem 61 SinuNase TM 61 alvimopan 61 leukemia AML 61 Nexavar ® 61 chronic eosinophilic leukemia 60 secondary hyperparathyroidism 60 Renal Cell Carcinoma RCC 60 onychomycosis 60 hepatitis C HCV 60 tolvaptan 60 methicillin susceptible Staphylococcus aureus 60 Cimzia ® certolizumab pegol 60 MabCampath 60 LHRH antagonists 60 receiving XGEVA 60 hepatic encephalopathy 60 rFVIIa 60 Raptiva ® 60 vaginal candidiasis 60 chronic GVHD 60 ribavirin RBV 60 heterozygous FH 60 UPLYSO 60 faropenem medoxomil 60 pheochromocytoma 60 dalbavancin 60 octreotide LAR 60 evaluating tivozanib 60 NATRECOR ® 60 Moxifloxacin 60 cephalosporin antibiotic 60 KETEK 60 DOXIL 60 STELARA TM 60 Camptosar ® 60 Dyloject TM 60 metastatic malignant 60 Personalized Immunotherapy 60 Gram positive 60 chronic HBV infection 60 relapsed refractory multiple myeloma 60 Evoltra ® 60 Eraxis 60 complement inhibitor eculizumab 60 Onychomycosis 60 Copegus ribavirin 60 receptor tyrosine kinase inhibitor 60 vWD 60 pegylated interferon alpha 60 atypical Hemolytic Uremic Syndrome 60 Peg IFN 60 AEGR 60 Aviptadil 60 Sudhir Agrawal D.Phil 60 Levofloxacin 60 calcineurin inhibitors 60 Primary IGFD 60 dextromethorphan quinidine 60 THALOMID 60 systemic immunosuppressive drugs 60 eosinophilic pneumonia 60 JAK inhibitor 60 interferon gamma 1b 60 post herpetic neuralgia 60 pyelonephritis 60 hyperphosphataemia 60 severe sepsis 60 Onrigin 60 Vandetanib 60 Clolar ® 60 diabetic gastroparesis 60 follicular lymphoma FL 60 SUTENT 60 investigational antiplatelet agent 60 Zometa zoledronic acid 60 heparin induced thrombocytopenia 60 renal toxicity 60 arterial thrombosis 60 remission induction 60 homozygous familial hypercholesterolemia 60 dirucotide MBP# 60 RoACTEMRA 60 Faropenem 60 metastatic malignant melanoma 60 mycophenolate mofetil 60 Neulasta ® 60 carcinoid syndrome 60 delafloxacin 60 oral levofloxacin 60 ADHF 60 acitretin 60 diarrhea CDAD 60 Hepatocellular Carcinoma HCC 60 methylnaltrexone bromide 60 Alvesco R 60 causative pathogen 60 diabetic neuropathic pain 60 FOSRENOL R 60 overactive bladder syndrome 60 sJIA 60 congenital ichthyosis 60 kidney urologic 60 R sorafenib tablets 60 Pegloticase 60 Cethromycin 60 toenail onychomycosis 60 LEUKINE 60 uncomplicated malaria 60 erlotinib Tarceva ® 60 ponatinib 60 AVONEX ® 60 CIMZIA ™ 60 ara C 60 Hedgehog Pathway Inhibitor 60 TNF alpha inhibitor 60 severe hypersensitivity reactions 60 SJIA 60 Octreotide 60 COPD exacerbations 60 lenalidomide dexamethasone 60 Acute Radiation Syndrome ARS 60 Amrubicin 60 APTIVUS r 60 oral rivaroxaban 60 Tarceva TM 60 trabectedin 60 Vaprisol 60 Fluconazole 60 linezolid 59 disease CDAD 59 cutaneous lupus 59 SUPPRELIN R LA 59 post herpetic neuralgia PHN 59 Tindamax R 59 Chronic Lymphocytic Leukemia CLL 59 metastatic GIST 59 macrolide antibiotics 59 ITAX 59 basal cell carcinoma BCC 59 Gleevec imatinib mesylate 59 AzaSite Plus 59 NEUPOGEN 59 noninfectious uveitis 59 HZT 59 relapsing remitting MS RRMS 59 cutaneous T 59 PEGINTRON 59 INTELENCE 59 PROMACTA 59 angioedema 59 Dacogen decitabine 59 SCH # 59 Skin Structure Infections ABSSSI 59 acute HAE attacks 59 pulmonary arterial hypertension PAH 59 oral candidiasis 59 Anidulafungin 59 RezularTM 59 DMARDS 59 DIFICID ™ 59 cystic fibrosis bronchiectasis 59 pegfilgrastim 59 exocrine pancreatic insufficiency EPI 59 nephrotoxicity 59 Staphylococcus aureus infections 59 Gemzar ® 59 Kit CD# positive 59 Firazyr 59 dasatinib Sprycel 59 serotype #A 59 antithrombotics 59 efalizumab 59 hyperphenylalaninemia HPA due 59 Streptococcus pyogenes 59 ALI ARDS 59 Omacetaxine 59 oral prodrug 59 Pfizer Sutent 59 TNF antagonist 59 Pegasys ® 59 superficial bladder cancer 59 Cimzia TM 59 abatacept 59 BCR ABL inhibitor 59 Ixempra 59 Golimumab 59 leukemia CLL 59 cidofovir 59 ezogabine 59 aflibercept 59 FOLOTYN ® 59 sorafenib Nexavar 59 visilizumab 59 allogeneic HSCT 59 severe malignant osteopetrosis 59 rheumatoid arthritis psoriatic arthritis 59 Oracea ® 59 ganciclovir 59 sorafenib Nexavar R 59 oral diclofenac 59 Allergic Rhinitis 59 HBeAg positive patients 59 fluconazole 59 S. aureus infections 59 Fludara ® 59 IMiDs ® compound 59 Streptococcus pneumoniae Haemophilus influenzae 59 HeFH 59 DPNP 59 gastrointestinal disorders characterized 59 Onrigin TM 59 Acute Bacterial Skin 59 INVEGA ® 59 relapsing multiple sclerosis 59 exocrine pancreatic insufficiency 59 ARCALYST ® 59 ertapenem 59 bronchitis sinusitis 59 posterior uveitis 59 refractory metastatic colorectal cancer 59 Irritable Bowel Syndrome IBS 59 acetonide FA 59 phase IIb clinical 59 primary hypercholesterolemia 59 relapsed SCLC 59 sargramostim 59 Octreolin 59 SEBIVO 59 Doxil ® 59 ACTEMRA 59 investigational monoclonal antibody 59 SSTIs 59 INTEGRILIN ® 59 acute GvHD 59 delayed CINV 59 oral ridaforolimus 59 TREANDA 59 interferon alfa 59 ocular allergies 59 Fludarabine 59 pegylated interferon alfa 59 lamivudine 3TC 59 CAELYX 59 INTEGRILIN 59 acute respiratory tract infections 59 pulmonary hypertension PH 59 Febrile neutropenia 59 iGVHD 59 SHPT 59 drug ISA# 59 Pulmonary Arterial Hypertension PAH 59 pain palliation 59 Cariprazine 59 Enterococcus faecium 59 Entereg R 59 meropenem 59 Dasatinib 59 Aflibercept 59 JANUVIA 59 injectable antibiotic 59 Urocidin TM 59 bacterial respiratory infections 59 treatment naive genotype 59 canakinumab 59 Tolvaptan 59 peginterferon alfa 59 Staphylococcus aureus bloodstream infections 59 Aloxi injection 59 systemic lupus erythematosus psoriasis 59 boosted protease inhibitor 59 macrolide antibiotic 59 retinal vein occlusion 59 Pivotal Phase III 59 Phase IIIb clinical 59 thalidomide Thalomid 59 CIMZIA TM certolizumab pegol 59 Nebulized 59 romiplostim 59 icatibant 59 refractory Hodgkin lymphoma 59 Pruvel 59 CINTREDEKIN BESUDOTOX 59 systemic ALCL 59 chronic rhinosinusitis 59 relapsed CLL 59 Atypical Hemolytic Uremic Syndrome 59 vandetanib 59 herpes zoster shingles 59 Quetiapine 59 sublingual tablets 59 Drug Eluting Stent System 59 antiarrhythmic drug 59 PROCRIT ® 59 Sanvar R 59 temsirolimus Torisel ® 59 eosinophilic asthma 59 fluoroquinolone antibiotic 59 sitaxsentan 59 vapreotide acetate 59 ONCASPAR 59 fibromyalgia syndrome 59 FIRAZYR 59 riociguat 59 Keppra R 59 docetaxel Taxotere R 59 Taxotere ® 58 APTIVUS 58 Torisel 58 HCV SPRINT 58 Hyphanox 58 hepatorenal syndrome 58 active ankylosing spondylitis 58 ATACAND 58 pegylated interferon alfa 2a 58 Lubiprostone 58 FROVA 58 acute bacterial sinusitis 58 induced macular edema 58 salmeterol fluticasone 58 hepatic failure 58 Thrombocytopenia 58 comparator arm 58 postherpetic neuralgia PHN 58 alkylating agent 58 reduce serum phosphate 58 MyVax R 58 Candida infection 58 Increlex ® 58 caspofungin 58 Tindamax 58 Eltrombopag 58 KRAS mutations occur 58 plasma kallikrein inhibitor 58 FOLFIRI 58 pomalidomide 58 AzaSite TM 58 Investigational Treatment 58 AGILECT ® 58 Proxinium TM 58 Alemtuzumab 58 Arixtra 58 EOquin TM 58 prucalopride 58 Prulifloxacin 58 immuno compromised patients 58 Exacerbations 58 OMNARIS Nasal Spray 58 vemurafenib 58 Increlex R 58 FACTIVE R gemifloxacin 58 Bezielle 58 relapsed ovarian cancer 58 hematologic adverse 58 neutropenia dehydration dyspnea 58 OHR/AVR# 58 ALVESCO 58 Phase IIb clinical trials 58 thromboprophylaxis 58 hematological malignancy 58 aprepitant 58 platelet inhibitor 58 RSV infection 58 arthritis PsA 58 Eloxatin R 58 VPRIV 58 Erythropoietic therapies may 58 diabetic peripheral neuropathy 58 telbivudine 58 ELOXATIN 58 Amigal 58 histamine dihydrochloride 58 CRVO 58 ARIXTRA 58 Avelox 58 quinolone 58 Certican 58 postoperative ileus 58 steroid refractory GvHD 58 stage IIIB 58 PREZISTA rtv 58 PD LID 58 oxymorphone ER 58 antifungal therapy 58 chronic bronchitis AECB 58 Lung transplantation 58 NYHA Class II 58 Omalizumab 58 amrubicin 58 relapsed leukemia 58 acute PAO 58 Zenvia Phase III 58 gastrointestinal GI motility disorders 58 platinum refractory 58 cabazitaxel 58 tipranavir 58 Alinia 58 Oracea TM 58 antibiotic regimens 58 nucleoside analogs 58 Chronic lymphocytic leukemia 58 Severe VOD 58 temsirolimus 58 VAPRISOL 58 PegIFN RBV 58 pemphigus vulgaris 58 beclomethasone dipropionate 58 Liprotamase 58 Targretin 58 atherothrombotic disease 58 Pseudomonas aeruginosa infections 58 PEGylated anti 58 active comparator 58 rilonacept 58 chronic periodontitis 58 steroid dexamethasone 58 Chlamydia trachomatis 58 Raptiva R 58 sodium stibogluconate 58 Natroba 58 obatoclax 58 brand ciclesonide HFA 58 TELINTRA 58 TAXOTERE ® 58 INTEGRILIN R 58 briakinumab 58 mediastinitis 58 EOquin 58 Bortezomib 58 APTIVUS ritonavir 58 postoperative ileus POI 58 neurological manifestations 58 Paraplatin ® 58 painful diabetic neuropathy 58 levofloxacin 58 adalimumab Humira 58 antimuscarinic 58 nonsevere 58 mycosis fungoides 58 ritonavir boosted 58 incidence ≥ 58 hypophosphatasia 58 S. aureus bloodstream infections 58 constipation OIC 58 Pentacel vaccine 58 Hycamtin 58 Overactive Bladder 58 EFAPROXYN 58 pancreatic NET 58 MAGE A3 ASCI 58 tacrolimus ointment 58 Ciclesonide 58 Cx# [002] 58 catheter occlusion 58 AEG# 58 TRISENOX 58 TEAEs 58 functional dyspepsia 58 Cimzia ® 58 Vidaza azacitidine 58 hypoparathyroidism 58 deforolimus 58 Idiopathic Pulmonary Fibrosis 58 gemifloxacin 58 Azathioprine 58 Kuvan R 58 hepatotoxicity 58 mixed dyslipidemia 58 Escherichia coli Klebsiella pneumoniae 58 neutropenic patients 58 fluoroquinolone resistance 58 Tavocept 58 Xcytrin R 58 BENLYSTA ® 58 cell lymphoma CTCL 58 symptomatic BPH 58 Phase #b/#a clinical 58 topical antibiotic 58 hereditary deficiency 58 dextofisopam 58 azacitidine 58 melphalan prednisone 58 evaluating REVLIMID 58 metastatic renal cell carcinoma 58 virus HCV protease inhibitor 58 patients receiving ERBITUX 58 ADP receptor antagonist 58 chronic constipation CC 58 headache nasopharyngitis 58 CYPHER Stent 58 Ozarelix 58 YONDELIS 58 MEK Inhibitor 58 Onco TCS 58 H. pylori eradication 58 Sporanox 58 etanercept Enbrel 58 systemic lupus erythematosus 58 Ticagrelor 58 imatinib resistant 58 acute otitis media 58 severe hypercholesterolemia 58 Fibrin Pad 58 Xyfid TM 58 YERVOY 58 disease GERD 58 acyclovir Lauriad ® 58 ORENCIA R 58 placebo controlled Phase III 58 ethambutol 58 VELCADE melphalan 58 Cleviprex TM clevidipine 58 hylan GF 58 virus HCV infection 58 post thrombotic syndrome 58 partial onset seizures 58 ISENTRESS 58 dihydrochloride Tablets 58 HuLuc# 58 Soliris TM eculizumab 58 desvenlafaxine succinate 58 alefacept 58 granulomatous 58 infliximab Remicade 58 cinacalcet 58 EXJADE 58 Prospective Randomized 58 hypercalcemia 58 ZOLINZA 58 trastuzumab Herceptin R 58 celgosivir 58 Mipomersen 58 pharyngitis tonsillitis 58 clevidipine 58 Gleevec Glivec 58 pancreatic neuroendocrine tumors 58 tobramycin 58 Ribavirin causes 58 Pivotal Phase 58 novel emulsion formulation 58 STELARA ™ 58 empiric treatment 58 dopaminergic therapy 58 Elagolix 57 anagrelide 57 Ganciclovir 57 Neutropenia 57 MAA submission 57 Lactic acidosis 57 everolimus tablets 57 Rectogesic 57 Besivance 57 Nexavar sorafenib 57 tanespimycin 57 neurogenic orthostatic hypotension 57 infective endocarditis 57 myelofibrosis polycythemia vera 57 Allovectin 7 ® 57 atrophic gastritis 57 gefitinib Iressa 57 anemia neutropenia 57 chronic plaque psoriasis 57 vancomycin 57 myocardial infarction ventricular fibrillation 57 atypical hemolytic uremic syndrome 57 cirrhosis liver failure 57 Entereg TM 57 hematologic toxicity 57 oral deforolimus 57 acute exacerbations 57 vismodegib 57 including eniluracil ADH 57 Civacir 57 Bronchitol 57 Trastuzumab 57 peginterferon alfa 2a 57 XIENCE V PROMUS Stent 57 delivers fluocinolone acetonide FA 57 tuberous sclerosis TS 57 Traficet EN 57 depression TRD 57 glucocorticoid induced osteoporosis 57 HoFH 57 Candidiasis 57 neovascular diseases 57 Peginterferon 57 tinidazole 57 gadobutrol 57 Folfox 57 susceptible isolates 57 DU #b 57 novel VDA molecule 57 Adalimumab 57 HuMax CD4 57 myeloproliferative neoplasms 57 varicella zoster virus VZV 57 Phase Ib clinical 57 genotypic resistance 57 secondary amenorrhea 57 null responder HCV 57 Mitoxantrone 57 Catena ® 57 regorafenib 57 Daclizumab 57 Rebetol 57 Myelofibrosis 57 Targretin capsules 57 docetaxel chemotherapy 57 Xanafide 57 C. trachomatis 57 dosing regimens 57 radezolid 57 Dapagliflozin 57 ELACYT 57 either acutely decompensated 57 miconazole 57 echinocandin 57 sunitinib Sutent 57 Helicobacter pylori eradication 57 immune thrombocytopenic purpura ITP 57 ridaforolimus 57 GI motility disorders 57 tocilizumab 57 rasagiline tablets 57 Bacteremia 57 ISTODAX 57 PAOD 57 Zorbtive TM 57 Pegasys peginterferon alfa 2a 57 PRTX 57 nitrofurantoin 57 decompensated liver disease 57 Keppra ® 57 HepaGam B TM 57 Benlysta belimumab 57 immunomodulatory therapy 57 BEXXAR 57 Phase 2b Clinical Trial 57 Rituxan rituximab 57 S. aureus infection 57 zidovudine AZT 57 BROVANA 57 TREDAPTIVE 57 SNT MC# 57 osteoporotic vertebral compression fractures 57 Microplasmin 57 Tamibarotene 57 intra abdominal abscess 57 Inhalation Aerosol 57 acute decompensated heart 57 metastatic CRC 57 blepharitis 57 prostate cancer HRPC 57 Streptococcus pneumoniae 57 autoantibody positive 57 systemic corticosteroids 57 TNF Tumor Necrosis Factor 57 cytotoxics 57 acute leukemias 57 HER2 positive metastatic breast 57 Tracleer R 57 HBeAg positive 57 acute pyelonephritis 57 palifermin 57 placebo controlled clinical 57 clotrimazole 57 Natalizumab 57 Trabectedin 57 recurrent glioblastoma multiforme 57 Shigatoxin producing E. coli 57 HuMax EGFr 57 Gleevec resistant 57 LHRH agonists 57 Plicera 57 reflux disease GERD 57 entecavir 57 MoxDuo IR 57 peripheral neuropathic pain 57 R lenalidomide 57 AA amyloidosis 57 phase IIb trial 57 Flu Cy 57 protease inhibitor PI 57 Non inferiority 57 TELCYTA 57 lopinavir r arm 57 investigational humanized monoclonal antibody 57 confirmatory Phase III 57 RSV infections 57 lipid lowering agents 57 FOLOTYN 57 Hycamtin ® 57 chronic ITP patients 57 alpha 2a 57 peritumoral brain edema 57 biodefense pathogens 57 unresectable stage 57 rhinosinusitis 57 mechanically ventilated patients 57 LibiGel ® 57 trospium 57 Meets Primary Endpoint 57 endometrial hyperplasia 57 bacterial vaginosis BV 57 CA MRSA infections 57 Panzem R NCD 57 peginterferon alfa 2a Pegasys 57 metastatic HRPC 57 REVLIMID R 57 acute coronary syndromes 57 cervical dysplasia 57 tumor lysis syndrome 57 EGFR inhibitors 57 NAGS deficiency 57 Methylnaltrexone 57 calcineurin inhibitor 57 pertuzumab 57 daclizumab 57 NeuroStar TMS Therapy 57 nociceptive pain 57 4mg/kg 57 Azilect ® 57 prednisone prednisolone 57 VP# [004] 57 Certolizumab pegol 57 Pivotal Study 57 tardive dyskinesia TD 57 Evoltra TM 57 IV Busulfex 57 febrile neutropenia 57 Eloxatin ® 57 Metastatic Colorectal Cancer 57 Bendamustine 57 vaginal yeast infections 57 lexidronam injection 57 Restanza 57 OvaRex ® MAb 57 nitazoxanide 57 deep venous thromboses 57 IRX 2 57 Chronic hepatitis C 57 respiratory tract infections 57 Topical Suspension 57 Phase IIa trials 57 bacteriuria 57 Phase Ib 57 mapatumumab 57 paclitaxel Taxol 57 huC# DM4 57 cervical lymph nodes 57 Recurrences 57 HCV RESPOND 2 57 veno occlusive disease 57 silodosin 57 Tekturna HCT 57 FDA APPROVES 57 ofatumumab 57 itraconazole Sporanox 57 overlapping toxicities 57 anti angiogenic therapy 57 ipratropium bromide 57 lichen planus 57 FOSRENOL 57 PNP inhibitor 57 PREOS 57 Angioedema 57 prospective multicenter study 57 leukemia ALL 57 HSCT 57 Zingo TM 57 TMS Therapy 57 KRAS mutant tumors 57 dabigatran etexilate 57 Isentress raltegravir 57 DDP# 57 acne vulgaris 57 recurrent herpes labialis 57 Ophena TM 57 thrombotic thrombocytopenic purpura TTP 57 topically applied SEPA 57 leukotriene receptor antagonist 57 ruboxistaurin 57 2 methoxyestradiol 57 RELOVAIR ™ 57 blinded randomized placebo controlled 57 cangrelor 57 hyperphosphatemia 57 dasatinib 57 Immunotherapeutic 57 Junovan 57 Itraconazole 57 post operative ileus 57 cytoreduction 57 Cutaneous T 57 methylnaltrexone 57 Acute Myeloid Leukaemia AML 57 Carvedilol 57 dyspnea pulmonary infiltrates pneumonitis 57 IV NSCLC 57 atovaquone 57 cancer cachexia 57 recurrent genital herpes 57 Acute Coronary Syndromes ACS